Jeffrey Daniel Bien, PA-C

Jeffrey Bien practices at Martin Health Physician Group - HOPD in Port Saint Lucie, Florida.

Jeffrey Bien's NPI, 1942572607, was assigned on January 27, 2012. Jeffrey Bien holds Florida license PA9106397.

Jeffrey Bien's primary practice is Martin Health Physician Group - HOPD, at 10000 Sw Innovation Way, Port Saint Lucie, FL 34987.

Jeffrey Bien's primary practice is Martin Health Physician Group - HOPD in Port Saint Lucie, Florida. Jeffrey Bien is also affiliated with Cleveland Clinic Martin North Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Jeffrey Bien to 1 more group practice or clinic, named with a free account. Jeffrey Bien's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Jeffrey Bien practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Jeffrey Bien's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Jeffrey Bien is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Jeffrey Bien is licensed in Florida.

Dmand AI lists chronic kidney disease among the conditions Jeffrey Bien treats.

CMS data shows 77 Medicare services from Jeffrey Bien across 2 procedure codes in 2024, for 104 Medicare patients. Medicare paid $4,274 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 104 Medicare patients who saw Jeffrey Bien in 2024. The largest group is 75 to 84, with 41 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jeffrey Bien's median patient age at 60, with 56% women.

In 2024, Jeffrey Bien wrote 36 Medicare Part D claims for 26 patients. 94% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $64 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Jeffrey Bien for performance year 2024, reported through an alternative payment model (APM). Jeffrey Bien accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Jeffrey Bien.

CMS Open Payments shows 1 general payment to Jeffrey Bien from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Ethicon Inc. paid the most, $117.